Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis

Abstract

This is the first study on drug survival for CsA treatment in AD. Older age was associated with decreased drug survival related to controlled AD and side-effects. An intermediate-to-high starting dose was associated with an increased drug survival related to ineffectiveness.